This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Etzioni, R. Articles by Goodman, G. Search for Related Content PubMed PubMed Citation Articles by Etzioni, R. Articles by Goodman, G. Social Bookmarking                         What's this?

Incorporating the Time Dimension in Receiver Operating Characteristic Curves: A Case Study of Prostate Cancer

Margaret Pepe, PhD

Gary Longton, MS

Chengcheng Hu, MS

Gary Goodman, MD

Early diagnosis of disease has potential to reduce morbidity and mortality. Biomarkers may be useful for detecting disease at early stages before it becomes clinically ap parent. Prostate-specific antigen (PSA) is one such marker for prostate cancer. This article is concerned with modeling receiver operating characteristic (ROC) curves as sociated with biomarkers at various times prior to the time at which the disease is detected clinically, by two methods. The first models the biomarkers statistically using mixed-effects regression models, and uses parameter estimates from these models to estimate the time-specific ROC curves. The second directly models the ROC curves as a function of time prior to diagnosis and may be implemented using software pack ages with binary regression or generalized linear model routines. The approaches are applied to data from 71 prostate cancer cases and 71 controls who participated in a lung cancer prevention trial. Two biomarkers for prostate cancer were considered: total serum PSA and the ratio of free to total PSA. Not surprisingly, both markers performed better as the interval between PSA measurement and clinical diagnosis decreased. Although the two markers performed similarly eight years prior to diagnosis, it appears that total PSA performed better than the ratio measure at times closer to diagnosis. The area under the ROC curve was consistently greater for total PSA than for the ratio four and two years prior to diagnosis and at the time of diagnosis. Key words: time- dependent ROC curves; biomarkers; diagnosis; prostate-specific antigen. (Med Decis Making 1999; 19:242-251)

Medical Decision Making, Vol. 19, No. 3, 242-251 (1999)
DOI: 10.1177/0272989X9901900303


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Cai, M. S. Pepe, Y. Zheng, T. Lumley, and N. S. Jenny The sensitivity and specificity of markers for event times Biostat., April 1, 2006; 7(2): 182 - 197. [Abstract] [Full Text] [PDF]

				S. G Baker, B. S Kramer, M. McIntosh, B. H Patterson, Y. Shyr, and S. Skates Evaluating markers for the early detection of cancer: overview of study designs and methods Clinical Trials, February 1, 2006; 3(1): 43 - 56. [Abstract] [PDF]

				M. S. Pepe, H. Janes, G. Longton, W. Leisenring, and P. Newcomb Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker Am. J. Epidemiol., May 1, 2004; 159(9): 882 - 890. [Abstract] [Full Text] [PDF]

				M. S. Pepe, R. Etzioni, Z. Feng, J. D. Potter, M. L. Thompson, M. Thornquist, M. Winget, and Y. Yasui Phases of Biomarker Development for Early Detection of Cancer J Natl Cancer Inst, July 18, 2001; 93(14): 1054 - 1061. [Full Text] [PDF]